AT378187B - Verfahren zur herstellung einer neuen kristallmodifikation des cimetidins - Google Patents

Verfahren zur herstellung einer neuen kristallmodifikation des cimetidins

Info

Publication number
AT378187B
AT378187B AT0352282A AT352282A AT378187B AT 378187 B AT378187 B AT 378187B AT 0352282 A AT0352282 A AT 0352282A AT 352282 A AT352282 A AT 352282A AT 378187 B AT378187 B AT 378187B
Authority
AT
Austria
Prior art keywords
cimetidine
producing
crystal modification
new crystal
modification
Prior art date
Application number
AT0352282A
Other languages
English (en)
Other versions
ATA352282A (de
Inventor
Janos Dipl Ing Dr Kreidl
Maria Dipl Ing Dr Farkas
Kalman Dipl Ing Dr Harsanyi
Bela Dipl Ing Dr Benke
Andras Dipl Ing Rado
Gyoergy Dipl Ing Dr Domany
Bela Dipl Ing Hegedues
Eva Dipl Ing Csongor
Ida Dr Deutsch
Hajnalka Pethoe
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of ATA352282A publication Critical patent/ATA352282A/de
Application granted granted Critical
Publication of AT378187B publication Critical patent/AT378187B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AT0352282A 1981-09-25 1982-09-22 Verfahren zur herstellung einer neuen kristallmodifikation des cimetidins AT378187B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU812767A HU185457B (en) 1981-09-25 1981-09-25 Process for preparating cimetidine-z

Publications (2)

Publication Number Publication Date
ATA352282A ATA352282A (de) 1984-11-15
AT378187B true AT378187B (de) 1985-06-25

Family

ID=10961014

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0352282A AT378187B (de) 1981-09-25 1982-09-22 Verfahren zur herstellung einer neuen kristallmodifikation des cimetidins

Country Status (10)

Country Link
US (1) US4537900A (de)
JP (1) JPS5867676A (de)
AT (1) AT378187B (de)
BE (1) BE894464A (de)
CY (1) CY1463A (de)
DE (1) DE3235459A1 (de)
FR (1) FR2513636B1 (de)
GB (1) GB2108117B (de)
HU (1) HU185457B (de)
NL (1) NL189461C (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA868957B (en) * 1985-12-06 1987-07-29 Yamanouchi Pharma Co Ltd Crystals of nalpha-(((s)-4-oxo-2-azetidinyl)carbonyl)-l-histidyl-l-prolinamide and process for producing the crystals
FR2593065B1 (fr) * 1986-01-22 1988-09-09 Smith Kline French Lab Couples effervescents, compositions effervescentes d'antagonistes h2 de l'histamine les contenant et leur preparation.
GB8618846D0 (en) * 1986-08-01 1986-09-10 Smithkline Beckman Corp Chemical process
GB8618847D0 (en) * 1986-08-01 1986-09-10 Smith Kline French Lab Pharmaceutical formulations
HU196775B (en) * 1986-08-05 1989-01-30 Richter Gedeon Vegyeszet Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances
JPH064601B2 (ja) * 1987-11-04 1994-01-19 三井石油化学工業株式会社 Ｎ−シアノ−ｎ’−メチル−ｎ’’−［２−｛（５−メチル−１ｈ−イミダゾール−４−イル）メチルチオ｝エチルグアニジンの精製法
US5808090A (en) * 1996-02-22 1998-09-15 Endo Pharmaceuticals Inc. Process for preventing precipitation in cimetidine injection solutions
US20040265440A1 (en) * 2002-09-16 2004-12-30 Agcert International, Llc Food borne pathogen sensor and method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ184893A (en) * 1976-09-21 1980-11-28 Smith Kline French Lab Pure crystalline form of cimetidine a(n-methyl-n-cyano-n-(-2-(5-methyl-4imidazolyl) methylthio) ethyl)-guanidine andpharmaceutical compositions containing it
JPS56104868A (en) * 1980-01-24 1981-08-20 Fujimoto Seiyaku Kk Conversion between polymorphous crystals of cimetidine

Also Published As

Publication number Publication date
CY1463A (en) 1989-07-21
DE3235459A1 (de) 1983-04-14
DE3235459C2 (de) 1991-11-28
GB2108117A (en) 1983-05-11
NL189461B (nl) 1992-11-16
GB2108117B (en) 1985-10-30
JPS5867676A (ja) 1983-04-22
JPH0357895B2 (de) 1991-09-03
NL189461C (nl) 1993-04-16
US4537900A (en) 1985-08-27
NL8203688A (nl) 1983-04-18
FR2513636A1 (fr) 1983-04-01
HU185457B (en) 1985-02-28
FR2513636B1 (fr) 1986-02-28
ATA352282A (de) 1984-11-15
BE894464A (fr) 1983-03-22

Similar Documents

Publication Publication Date Title
AT375945B (de) Verfahren zur herstellung von neuen erythromycin a-verbindungen
AT377524B (de) Verfahren zur herstellung von neuen anthracyclinglycosiden
AT382612B (de) Verfahren zur herstellung von neuen arylcyclobutylalkylaminen
AT384017B (de) Verfahren zur herstellung von neuen hydroxyaminoestern
AT381091B (de) Verfahren zur herstellung von neuen ergolinderivaten
AT386199B (de) Verfahren zur herstellung von neuen 2-piperazinopyrimidinen
AT378187B (de) Verfahren zur herstellung einer neuen kristallmodifikation des cimetidins
AT375943B (de) Verfahren zur herstellung von neuen mitosanverbindungen
AT376222B (de) Verfahren zur herstellung von neuen azinorifamycinverbindungen
AT380477B (de) Verfahren zur herstellung von neuen spirothiazolidindion-derivaten
ATA208784A (de) Verfahren zur herstellung einer neuen kamillensorte (bezeichnung manzana)
AT384214B (de) Verfahren zur herstellung von neuen mercaptoacylcarnitinen
ATA139685A (de) Verfahren zur herstellung von neuen cephalosporinverbindungen
ATA189286A (de) Verfahren zur herstellung einer neuen neodymverbindung
AT381318B (de) Verfahren zur herstellung von neuen nitrosoharnstoffderivaten
AT377264B (de) Verfahren zur herstellung von neuen nitrosoharnstoffderivaten
AT381722B (de) Verfahren zur herstellung einer neuen carcinostatischen substanz
AT381939B (de) Verfahren zur herstellung von neuen azaspiroalkandionen
AT374199B (de) Verfahren zur herstellung einer neuen oxathiaverbindung und ihrer salze
AT378186B (de) Verfahren zur herstellung von cimetidin
ATA59188A (de) Verfahren zur herstellung einer neuen cephalosporinverbindung
ATA330184A (de) Verfahren zur herstellung einer neuen thiadiazolverbindung
AT387021B (de) Verfahren zur herstellung einer cephalosporinverbindung
AT378185B (de) Verfahren zur herstellung eines neuen cimetidin-monohydrats
ATA100082A (de) Verfahren zur herstellung einer neuen geschaeumten suessware

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee